Dilution of Share Value Resulting from the Exercise of Stock Options
First written in FY2016. 12 of 33 entries say "Materialised", first in FY2017-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026Decrease in potential shares and increase in dilution rateAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares represented by these stock acquisition rights was 513,900, equivalent to 3.7% of the 13,742,956 issued shares outstanding as of 31 March 2026, excluding treasury shares.」
The number of potential shares declined from 524,900 at the end of the previous fiscal year to 513,900, while the ratio to issued shares excluding treasury shares rose from 3.1% to 3.7% due to share repurchases. - FY2026-H1SoftenedAnnual report
「株式会社ホープ Tenth Series Stock Acquisition Rights (Number of stock acquisition rights: 409)」
The number of Tenth Series Stock Acquisition Rights declined from 419 at the end of the previous consolidated fiscal year to 409, resulting in a slight reduction in potential dilution exposure. - FY2025-H1MaterialisedAnnual report
「1 April 2024–30 September 2024 7,000 16,465,800 1,093 11,812 1,093 1,812 (Note) The increase resulted from the exercise of stock acquisition rights under the stock option plan.」
During the interim consolidated accounting period, 7,000 shares were issued through the exercise of stock acquisition rights under the stock option plan, with part of the dilution exposure materialising as actual share issuance. - FY2024SoftenedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares represented by these stock acquisition rights was 524,900, equivalent to 3.1% of the total number of issued shares including potential shares, or 16,983,700 shares.」
While 4,600 shares were issued during the period through the exercise of stock acquisition rights, the potential share ratio at the year-end was 3.1%, down from the significantly higher dilution levels in prior years. - FY2024-Q2MaterialisedAnnual report
「17 October 2023–27 December 2023 4,400 16,458,600 687 10,687 687 687 (Note) The increase resulted from the exercise of stock acquisition rights.」
Between October and December 2023, 4,400 shares were issued through the exercise of stock acquisition rights, with part of the dilution exposure materialising as actual share issuance. - FY2024-Q1MaterialisedAnnual report
「The 200-share increase in the total number of issued common shares resulted from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 200 shares, with part of the dilution from potential shares materialising as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「Eleventh Series Stock Acquisition Rights Third quarter accounting period (1 October 2022 to 31 December 2022) Number of such stock acquisition rights with provisions for adjustment of the exercise price exercised during the quarter 8,800 Number of shares delivered upon exercise during the quarter 880,000 Funds raised through exercises during the quarter (¥ thousand) 237,600 Cumulative number of such stock acquisition rights exercised as of the end of the quarter 38,741 Cumulative number of shares delivered in respect of such stock acquisition rights as of the end of the quarter 3,874,100 Cumulative funds raised in respect of such stock acquisition rights as of the end of the quarter (¥ thousand) 1,191,242」
The exercise of the Eleventh Series Stock Acquisition Rights resulted in the delivery of 880,000 shares during the quarter, bringing cumulative shares delivered to 3,874,100 and cumulative funds raised to ¥1,191.242 million. In addition, 2,585,000 shares were issued through a third-party allotment to チェンジ by the filing date, with capital raised and dilution through share issuance progressing. - FY2023-Q1MaterialisedAnnual report
「Eleventh Series Stock Acquisition Rights Number of such stock acquisition rights with provisions for adjustment of the exercise price exercised during the quarter 6,200 Number of shares delivered upon exercise during the quarter 620,000 Cumulative number of such stock acquisition rights exercised as of the end of the quarter 29,941 Cumulative number of shares delivered in respect of such stock acquisition rights as of the end of the quarter 2,994,100」
The exercise of the Eleventh Series Stock Acquisition Rights resulted in the delivery of 620,000 shares during the quarter, bringing cumulative shares delivered to 2,994,100. Dilution exposure from stock acquisition rights materialised as an additional share issuance. - FY2022-Q4MaterialisedAnnual report
「26 May 2022 (Note 1) 200 11,239,700 31 2,716,633 31 2,670,433 (Note 1) The increase resulted from the exercise of stock acquisition rights under the stock option plan.」
The exercise of stock acquisition rights under the stock option plan resulted in the issuance of 200 shares, with part of the dilution from potential shares materialising as actual share issuance. - FY2022Increase in Potential Shares, Decline in PercentageAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares represented by these stock acquisition rights was 3,283,500, equivalent to 22.6% of the total number of issued shares including potential shares, or 14,523,000 shares.」
The number of potential shares increased from 2,888,500 in the previous period, while the ratio to total issued shares including potential shares declined from 27.1% to 22.6%. - FY2022-Q2MaterialisedAnnual report
「Eleventh Series Stock Acquisition Rights Second quarter accounting period (1 October 2021 to 31 December 2021) Number of such stock acquisition rights with provisions for adjustment of the exercise price exercised during the quarter (rights): 18,360 Number of shares delivered upon exercise during the quarter (shares): 1,836,000」
The exercise of the Eleventh Series Stock Acquisition Rights resulted in the delivery of 1,836,000 shares during the quarter. Dilution from potential shares materialised as an additional share issuance. - FY2022-Q1MaterialisedAnnual report
「The 907,400-share increase in the total number of issued common shares resulted from the exercise of stock acquisition rights.」Maximum number of shares allocated: 5,000,000 (58.51% of the total number of issued shares as of the issuance approval date)」
The exercise of the Ninth and Eleventh Series Stock Acquisition Rights resulted in the actual issuance of 907,400 shares. In addition, potential shares equivalent to a maximum of 5 million shares, or 58.51% of the total number of issued shares, were established under the Eleventh Series Stock Acquisition Rights, further expanding dilution exposure. - FY2021Large stock acquisition rights issued after the year-end dilution ratio declinedAnnual report
「As of the end of the consolidated fiscal year, the number of potential shares represented by these stock acquisition rights was 2,888,500, equivalent to 27.1% of the total number of issued shares including potential shares, or 10,663,600 shares.」
The potential share ratio at the year-end declined from the previous disclosure, due in part to the exercise of some Ninth Series Stock Acquisition Rights. Meanwhile, the issuance by the filing date of Eleventh Series Stock Acquisition Rights for 5,000,000 shares was also disclosed, expanding subsequent dilution exposure. - FY2021-Q3WorsenedAnnual report
「株式会社ホープ Ninth Series Stock Acquisition Rights (4) Class and number of shares underlying the stock acquisition rights 3,304,500 common shares of the Company 株式会社ホープ Tenth Series Stock Acquisition Rights (4) Class and number of shares underlying the stock acquisition rights 58,400 common shares of the Company」
The issuance was approved of Ninth Series Stock Acquisition Rights for 3,304,500 shares and Tenth Series Stock Acquisition Rights for 58,400 shares, significantly expanding potential dilution exposure. Meanwhile, the remaining Seventh Series Stock Acquisition Rights, comprising 1,000 rights and 100,000 shares, are scheduled to be acquired and cancelled. - FY2021-Q2MaterialisedAnnual report
「During the second quarter accounting period, stock acquisition rights with provisions for adjustment of the exercise price and exercise approval were exercised as follows.」
During the quarter, 3,000 stock acquisition rights were exercised, 300,000 shares were delivered and ¥1,617 million was raised. Dilution from potential shares has materialised as an additional share issuance. - FY2021-Q1MaterialisedAnnual report
「株式会社ホープ Seventh Series Stock Acquisition Rights (approved by the Board of Directors on 11 August 2020) Class and number of shares underlying these stock acquisition rights: ※ Common shares: 400,000 (Note 1) 株式会社ホープ Eighth Series Stock Acquisition Rights (approved by the Board of Directors on 11 August 2020) Class, details and number of shares underlying these stock acquisition rights: ※ Common shares: 60,000 After the end of the first quarter accounting period and by 13 November 2020, part of the 株式会社ホープ Seventh Series Stock Acquisition Rights issued by the Company on 2 September 2020, with provisions for adjustment of the exercise price and exercise approval, had been exercised.」
The Company issued Seventh Series Stock Acquisition Rights for 400,000 shares and Eighth Series Stock Acquisition Rights for 60,000 shares for employees, and issued a further 65,000 shares through the exercise of the Seventh Series Stock Acquisition Rights by the filing date. The additional dilution exposure and its partial materialisation were disclosed. - FY2020Additional issuance plan after the year-end dilution ratio declinedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 536,800, equivalent to 8.2% of the total number of issued shares including potential shares, or 6,539,600 shares.」
The potential share ratio at the year-end fell from 14.8% in the previous fiscal year to 8.2%. Meanwhile, after the filing date, the issuance was disclosed of Seventh Series Stock Acquisition Rights for 400,000 shares through a third-party allotment and Eighth Series Stock Acquisition Rights for 60,000 shares for employees. - FY2020-Q3MaterialisedAnnual report
「After the end of the third accounting period, stock acquisition rights were exercised in respect of the Second Series Stock Acquisition Rights issued by the Company on 14 January 2014 and the Second Series Stock Acquisition Rights for fiscal 2017 issued on 26 August 2016. Exercises of stock acquisition rights from 1 April 2020 to 8 May 2020 were as follows: (1) Second Series Stock Acquisition Rights ① Number of stock acquisition rights exercised: 35 ② Class and number of shares issued: common shares, 140,000 (2) Second Series Stock Acquisition Rights for fiscal 2017 ① Number of stock acquisition rights exercised: 695 ② Class and number of shares issued: common shares, 278,000」
Stock acquisition rights were exercised between 1 April 2020 and 8 May 2020, resulting in the issuance of 418,000 shares in total. Dilution exposure from potential shares has materialised as actual share issuance. - FY2020-Q2RestatedAnnual report
「During the cumulative second-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
No material change was reported in the risk of dilution of equity value from the exercise of stock acquisition rights. - FY2020-Q1RestatedAnnual report
「(2) [Status of Stock Acquisition Rights and Other Items] ① [Details of the Stock Option Plan] Not applicable. ② [Status of Other Stock Acquisition Rights and Other Items] Not applicable.」
No new matters concerning stock acquisition rights or other related items were disclosed for the first quarter accounting period. - FY2019SoftenedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 242,850, equivalent to 14.8% of the total number of issued shares including potential shares, or 1,637,050 shares.」
The number of potential shares declined slightly from 244,700 in the previous fiscal year to 242,850, while the ratio fell from 14.9% to 14.8%. - FY2019-Q3RestatedAnnual report
「② Status of Other Stock Acquisition Rights, etc. Not applicable.」
No new matters concerning stock acquisition rights or other related items were disclosed for the third quarter accounting period. - FY2019-Q2RestatedAnnual report
「(2) [Status of Stock Acquisition Rights, etc.] There are no applicable items.」
No new matters concerning stock acquisition rights or other related items were disclosed for the second quarter accounting period. - FY2019-Q1RestatedAnnual report
「(2) [Status of Stock Acquisition Rights, etc.] There are no applicable items.」
No new matters concerning stock acquisition rights or other related items were disclosed for the first quarter accounting period. - FY2018WorsenedAnnual report
「As of the end of the fiscal year, the number of potential shares represented by these stock acquisition rights was 244,700, equivalent to 14.9% of the total number of issued shares including potential shares, or 1,638,900 shares.」
The number of potential shares increased from 106,500, or 7.09%, in the previous fiscal year to 244,700, or 14.9%, expanding dilution exposure. - FY2018-Q3RestatedAnnual report
「The share acquisition rights issued during the third-quarter accounting period are as follows. 株式会社ホープ 2018 Series 1 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) 118,500 株式会社ホープ 2018 Series 2 Share Acquisition Rights Number of shares underlying the share acquisition rights (shares) 20,900」
The 2018 Series 1 and Series 2 share acquisition rights issued during the third-quarter accounting period covered a total of 139,400 shares. The increase in potential dilution exposure disclosed in the previous quarter is also confirmed in the share acquisition rights position for the current quarter. - FY2018-Q2WorsenedAnnual report
「Total number of share acquisition rights to be issued 1,185 rights (100 shares per share acquisition right) Common shares of the company 118,500 shares Total number of share acquisition rights to be issued 418 rights (50 shares per share acquisition right) Common shares of the company 20,900 shares」
As a material subsequent event, the 2018 Series 1 and Series 2 share acquisition rights were issued, adding potential shares covering a total of 139,400 shares. Potential exposure to dilution of equity value has increased. - FY2018-Q1RestatedAnnual report
「During the cumulative first-quarter period, no new business or other risks arose. In addition, there were no significant changes to the business and other risks described in the securities report for the previous fiscal year.」
The risk section reports no material changes regarding dilution of equity value resulting from the exercise of share acquisition rights. - FY2017WorsenedAnnual report
「As of the end of the fiscal year under review, the number of potential shares attributable to these share acquisition rights was 106,500, representing 7.09% of the total number of issued shares, including potential shares, of 1,500,700.」
The number of potential shares increased from 41,000, or 2.86%, in the previous disclosure to 106,500, or 7.09%, expanding potential exposure to dilution. - FY2017-Q3RestatedAnnual report
「(2) [Status of Stock Acquisition Rights, etc.] There are no applicable items.」
The third-quarter report contains no new information regarding share acquisition rights or similar instruments, and no new changes following the share issuance identified in the previous quarter can be confirmed from the text. - FY2017-Q2MaterialisedAnnual report
「1 October 2016 to 31 December 2016 4,000 1,394,200 1,306 246,945 1,306 200,745 (Note) The increase resulted from the exercise of share acquisition rights as stock options.」
The issuance of 4,000 shares through the exercise of share acquisition rights as stock options shows part of the dilution risk from potential shares becoming actual share issuance. - FY2017-Q1WorsenedAnnual report
「株式会社ホープ 2017 Series 1 Share Acquisition Rights (approved by the Board of Directors on 9 August 2016) Number of share acquisition rights (rights) 433 Number of shares underlying the share acquisition rights (shares) 43,300 株式会社ホープ 2017 Series 2 Share Acquisition Rights (approved by the Board of Directors on 9 August 2016) Number of share acquisition rights (rights) 695 Number of shares underlying the share acquisition rights (shares) 69,500」
New share acquisition rights covering a total of 112,800 shares were issued, increasing potential exposure to dilution of equity value. Although the share acquisition rights were issued, dilution resulting from their exercise had not been confirmed at this point. - FY2016First statedAnnual report
「As of the end of the fiscal year under review, the number of potential shares attributable to these share acquisition rights was 41,000, representing 2.86% of the total number of issued shares, including potential shares, of 1,431,200.」
The company quantifies the potential dilution of issued shares resulting from the exercise of share acquisition rights granted to officers and employees.